Overcoming Resistance to PD-1 Blockade in Malignant Pleural Mesothelioma
In this first part of the Faculty Research Grant Program presentation, Dr. Bryan Burt, M.D. discusses his research in tumor-infiltrating B-cells working as regulators of PD-1 blockade in lung cancer. He shares the methods employed in his research, including some novel approaches to cell analysis, as well as preliminary data and clinical findings.
Target Audience
This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Learning Objectives
At the conclusion of the session, the participants should be able to:
Discuss the prognosis of malignant pleural mesothelioma.
Discuss contemporary treatment strategies for malignant pleural mesothelioma.
Explain known mechanisms of checkpoint blockade immunotherapy.
John Goss, M.D., Planning Committee Member
Professor and Chief
Department of Surgery, Division of Abdominal Transplantation
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Scott LeMaire, M.D., Planning Committee Member
Professor
Department of Surgery, Section of Cardiothoracic Surgery
Baylor College of Medicine
Houston, Texas
Disclosure: Research support: Terumo Aortic, WL Gore and Associates, CytoSorbants; Intellectual property: Blackwell Publishing, Wiley Publishing; Advisory committee membership: Biom'up; Consultancy: Terumo Aortic.
Todd Rosengart, M.D., Planning Committee Member
Professor and Chair
Department of Surgery
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Shawn Stafford, M.D., Contributor
Assistant Professor
Department of Surgery
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose
James Suliburk, M.D., Planning Committee Member
Associate Professor and Chief
Department of Surgery, Section of Endocrine Surgery
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation